Back to User profile » Dr Joseph Tauber

Papers published by Dr Joseph Tauber:


Systane iLux Thermal Pulsation System in the Treatment of Meibomian Gland Dysfunction: A Post-Hoc Analysis of a 12-Month, Randomized, Multicenter Study

Wesley G, Bickle K, Downing J, Fisher B, Greene B, Heinrich C, Kading D, Kannarr S, Miller J, Modi S, Ludwick D, Tauber J, Yeh TN, Srinivasan S

Clinical Ophthalmology 2022, 16:3631-3640

Published Date: 3 November 2022

Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial

Silverstein S, Yeu E, Tauber J, Guillon M, Jones L, Galarreta D, Srinivasan S, Manoj V

Clinical Ophthalmology 2020, 14:3167-3177

Published Date: 9 October 2020

A Comparison of Efficacy and Safety of Two Lipid-Based Lubricant Eye Drops for the Management of Evaporative Dry Eye Disease

Jerkins G, Greiner JV, Tong L, Tan J, Tauber J, Mearza A, Srinivasan S

Clinical Ophthalmology 2020, 14:1665-1673

Published Date: 18 June 2020

Comparison of the iLUX and the LipiFlow for the Treatment of Meibomian Gland Dysfunction and Symptoms: A Randomized Clinical Trial

Tauber J, Owen J, Bloomenstein M, Hovanesian J, Bullimore MA

Clinical Ophthalmology 2020, 14:405-418

Published Date: 12 February 2020

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI

Clinical Ophthalmology 2019, 13:215-216

Published Date: 24 January 2019

A Phase II /III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease [Corrigendum]

Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI

Clinical Ophthalmology 2018, 12:2637-2638

Published Date: 14 December 2018

A Phase II/III, randomized, double-masked, vehicle-controlled, dose-ranging study of the safety and efficacy of OTX-101 in the treatment of dry eye disease

Tauber J, Schechter BA, Bacharach J, Toyos MM, Smyth-Medina R, Weiss SL, Luchs JI

Clinical Ophthalmology 2018, 12:1921-1929

Published Date: 2 October 2018